+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pyrazinamide"

From
From
Tuberculosis Therapeutics Market Report 2025 - Product Thumbnail Image

Tuberculosis Therapeutics Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Anti-Tuberculosis Therapeutics Market 2025-2033 - Product Thumbnail Image

Anti-Tuberculosis Therapeutics Market 2025-2033

  • Report
  • March 2025
  • 146 Pages
  • Global
From
Tuberculosis - Pipeline Insight, 2025 - Product Thumbnail Image

Tuberculosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Pyrazinamide is a drug used to treat respiratory diseases, such as tuberculosis. It is a prodrug, meaning it is converted to an active form in the body. It is usually used in combination with other drugs, such as isoniazid and rifampicin, to treat tuberculosis. Pyrazinamide is also used to treat other respiratory diseases, such as Mycobacterium avium complex (MAC) and Mycobacterium kansasii. Pyrazinamide is available in both oral and injectable forms. It is generally well tolerated, with few side effects. However, it can cause liver damage in some patients, so it is important to monitor liver function when taking this drug. The pyrazinamide market is a growing one, with many companies offering products. Some of these companies include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more